Lovelace Medical Center-Saint Joseph Square

Summary

Lovelace Medical Center-Saint Joseph Square is a medical facility located in Albuquerque, New Mexico. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Prostate Cancer and other specialties. Lovelace Medical Center-Saint Joseph Square is involved with conducting 101 clinical trials across 300 conditions. There are 14 research doctors associated with this hospital, such as Atul Kumar, Carolyn Y. Muller, Ursa A. Brown-Glaberman, and Neda Hashemi Sadraei.

Top PIs

Clinical Trials running at Lovelace Medical Center-Saint Joseph Square

Lung Cancer

Breast Cancer

Esophageal cancer

Multiple Myeloma

Cancer

Colorectal Cancer

Melanoma

Bladder Cancer

Kidney Cancer

Non-Small Cell Lung Cancer

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.

Recruiting

2 awards

Phase 3

27 criteria

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria

Cannabis Use

for Breast Cancer

This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies with chemotherapy and/or (immune checkpoint inhibitors) ICIs.

Recruiting

1 award

N/A

10 criteria